NASDAQ:BCYC | Free Cash Flow | BICYCLE THERAPEUTICS PLC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$65.93M$713,000.00-$66.64M
2025-12-31-$19.35M$574,000.00-$19.92M
2025-03-31-$86.37M$604,000.00-$86.97M
2024-12-31-$9.4M$368,000.00-$9.76M
2024-03-31-$70.87M$12,000.00-$70.88M
2023-12-31-$47.29M$51,000.00-$47.34M
2023-03-31-$46.41M$2.1M-$48.51M
2022-12-31-$30.31M$1.45M-$31.76M
2022-03-31-$26.4M$4.76M-$31.16M
2021-12-31-$10.44M$1.07M-$11.5M
2021-03-31-$13.71M$623,000.00-$14.33M
2020-12-31-$16.62M$484,000.00-$17.1M
2020-03-31$21.16M$320,000.00$20.84M
2019-12-31-$4.92M$391,000.00-$5.31M
2019-03-31-$5.2M$418,000.00-$5.62M
2018-12-31-$8.85M$410,000.00-$9.26M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$249.68M$2.35M-$252.03M
2024-12-31-$164.72M$1.24M-$165.96M
2023-12-31-$60.63M$2.93M-$63.56M
2022-12-31-$86.11M$18.99M-$105.1M
2021-12-31-$14.79M$2.03M-$16.82M
2020-12-31-$17.79M$1.2M-$18.99M
2019-12-31-$28.61M$1.56M-$30.17M
2018-12-31-$26.08M$1.19M-$27.26M
2017-12-31-$1.42M$1.11M-$2.53M